Athenex, Inc.
$0.20
+0.00 (+0.00%)
Open
$0.22
Prev. Close
Day Low
Day High
52W Low
$0.08
52W High
$23.80
Market Cap
$0.00B
Volume
1.75M
Athenex Announces Additional Licensing Agreements for Tirbanibulin
Athenex to Provide Corporate and Financial Update for the Second Quarter 2021 on August 5, 2021
Athenex Announces European Commission Approval of Klisyri® (tirbanibulin) for the Topical Treatment of Actinic Keratosis
Athenex Issues Update On Oral Paclitaxel Application In Metastatic Breast Cancer
Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer
SHAREHOLDER ALERT: Robbins LLP is Investigating Athenex, Inc. (ATNX) for Shareholders
Athenex Presents Data on Oral Docetaxel and Oral Paclitaxel at ASCO2021 Virtual Scientific Program